[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "One vaccine dose and two viral variants", "description": "Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine \n\nhttps://www.nejm.org/doi/full/10.1056/NEJMoa2034577\n\nNEJM, (December 31st)\n\nA two-dose regimen of BNT162b2 conferred 94.8% protection against Covid-19 in persons 16 years of age or older\n\nAfter 1 dose, efficacy = 52.4%\n\nNEJM, (17th February)\n\nBut if you take data after 2 weeks \u2026. \n\nhttps://www.nejm.org/doi/pdf/10.1056/NEJMc2036242?articleTools=true\n\nOne Pfizer dose, vaccine efficacy of 92.6% (based on FDA data)\n\nOne Moderna dose, vaccine efficacy of 92.1% (based on FDA data)\n\nUncertainty about duration of protection with a single dose\n\nAdministration of a second dose within 1 month, little added benefit in the short term\n\nLeaving high risk groups completely unprotected\n\nPostponement of the second dose is a matter of national security that, \n\nif ignored, will certainly result in thousands of Covid-19\u2013related hospitalizations and deaths this winter in the United States\n\nhospitalizations and deaths that would have been prevented with a first dose of vaccine. \n\nNZ and Australia begin vaccine rollout\n\nSaturday\n\nBorder staff\n\nManaged Isolation and Quarantine (MIQ) workers\n\nAustralia, Monday\n\nHotel quarantine and healthcare workers\n\nPfizer\n\nPfizer BioNTech\n\nhttps://www.telegraph.co.uk/global-health/science-and-disease/pfizer-coronavirus-vaccine-no-longer-needs-kept-super-cold-temperatures/\n\nUpdated stability data\n\nNormal medical freezer, -15C and -25C for up to two weeks \n\nInstead of -60C to -80C\n\nKept in a fridge for five days\n\nAwaiting US Food and Drug Administration (FDA) approval\n\n(Moderna, normal fridge temperature, 2C and 8C for 30 days)\n\nVaccine passports\n\nProfessor Dominic Wilkinson, Medical Ethics, Oxford University\n\nI think there\u2019s a strong ethical case for exploring immunity passports as a way forward, as a way of looking forward to more freedoms\n\nopen up some options in travel that are not there at the moment\n\nIf there was good evidence that you weren\u2019t at risk of spreading the virus, \n\nsuch a passport might then allow you to be waived from quarantine.\u201d\n\nwould be a cost to waiting until more people are immunised to roll out the passports.\n\nDigital vaccine passports\n\nBahrain\n\nDenmark\n\nSweden\n\nSecret antiviral meds?\n\nhttps://www.telegraph.co.uk/global-health/science-and-disease/coronavirus-news-vaccine-r-rate-covid-lockdown-end-cases-deaths/\n\neSwatini's King Mswati III (Swaziland)\n\ntested positive in January, now negative\n\nsaid he had recovered from Covid-19\n\nTaiwan President Tsai Ing-wen sent antiviral medication\n\nRecombination variant\n\nhttps://www.nyas.org/events/2021/webinar-the-quest-for-a-covid-19-vaccine/\n\nhttps://www.newscientist.com/article/2268379-two-coronavirus-variants-have-merged-heres-what-you-need-to-know/\n\nhttps://www.sciencedirect.com/science/article/pii/B9780128096338209588\n\nThe UK and California variants, B.1.1.7 and B.1.429\n\nCombined genomes into a heavily mutated hybrid\n\nDiscovered in a virus sample in Los Alamos, National Laboratory\n\nMay be how SARS-CoV-2 originated\n\nOne cell, two viral variants\n\nMultiple variants in circulation, more likely to occur\n\nWorst outcome, more transmissible and more antibody resistant", "link": "https://www.youtube.com/watch?v=is7XpudFGJ8", "date_published": "2021-02-20 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]